Add Yahoo as a preferred source to see more of our stories on Google. Messenger RNA, full name messenger ribonucleic acid, is a molecule in the body that carries instructions to make proteins. “To ...

In this podcast, recorded at the 2024 Immuno-Oncology 360º Summit, Dr Margaret Callahan, University of Connecticut, goes over the history of tumor vaccines in immuno-oncology, particularly the lessons ...

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

A vaccine combined with Keytruda is associated with a 49% reduction in the risk of recurrence or death. Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer ...

In a breakthrough in cancer treatment, Russia’s cancer vaccine has completed preclinical trials demonstrating both safety and high efficacy., Veronika Skvortsova, head of the Federal Medical and ...

Driving RNA vaccine innovation through microbiome insights is an emerging frontier that moves beyond pathogen-only thinking and toward vaccines designed ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

The vaccine could replace the need for separate annual jabs for flu, Covid and cold viruses as well as providing defence against new pathogens ...

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in mice to a hundred times its stand-alone effectiveness, thus offering ...

Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, showing it a wanted poster for a single suspect. But what if one vaccine could ...

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning its back on future development of mRNA vaccines spells more hard times for ...